Literature DB >> 10598835

Clinical spectrum and diagnostic difficulties of infantile ponto-cerebellar hypoplasia type 1.

F Muntoni1, F Goodwin, C Sewry, P Cox, F Cowan, E Airaksinen, S Patel, J Ignatius, V Dubowitz.   

Abstract

We present the clinical and histopathological features and the diagnostic difficulties encountered in five children affected by a motor neuron disorder other than spinal muscular atrophy. Investigations performed suggested the diagnosis of ponto-cerebellar hypoplasia type 1 (PCH-1). Severe respiratory difficulty was present at birth in two of these children; hypotonia, arthrogryposis, microcephaly and nystagmus were present in all. Early and progressive bulbar involvement with swallowing difficulties and stridor was also a common feature in these infants. Severe cognitive delay was invariably present. Brain magnetic resonance imaging showed ponto-cerebellar hypoplasia in four children while striking atrophy of the cerebellar vermis and cerebellar hemispheres were present in the fifth child. Electrophysiological and pathological investigations of proximal muscles performed at presentation in all these children were not conclusive, while the post-mortem studies, or the study of distal muscles during life, showed a clear neurogenic picture. Genetic studies excluded involvement of the SMN gene, or of other genes located on chromosome 5q, confirming that ponto-cerebellar hypoplasia type 1 is a different entity from typical proximal spinal muscular atrophy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10598835     DOI: 10.1055/s-2007-973498

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  6 in total

1.  Disruption of cerebellar development: potential complication of extreme prematurity.

Authors:  Agnes Messerschmidt; Peter C Brugger; Eugen Boltshauser; Gerlinde Zoder; Walter Sterniste; Robert Birnbacher; Daniela Prayer
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

2.  Inherited neuroaxonal dystrophy in dogs causing lethal, fetal-onset motor system dysfunction and cerebellar hypoplasia.

Authors:  John C Fyfe; Raba' A Al-Tamimi; Rudy J Castellani; Diana Rosenstein; Daniel Goldowitz; Paula S Henthorn
Journal:  J Comp Neurol       Date:  2010-09-15       Impact factor: 3.215

Review 3.  A developmental and genetic classification for midbrain-hindbrain malformations.

Authors:  A James Barkovich; Kathleen J Millen; William B Dobyns
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

4.  Pontocerebellar hypoplasia type 1: clinical spectrum and relevance of EXOSC3 mutations.

Authors:  Sabine Rudnik-Schöneborn; Jan Senderek; Joanna C Jen; Gunnar Houge; Pavel Seeman; Alena Puchmajerová; Luitgard Graul-Neumann; Ulrich Seidel; Rudolf Korinthenberg; Janbernd Kirschner; Jürgen Seeger; Monique M Ryan; Francesco Muntoni; Maja Steinlin; Laszlo Sztriha; Jaume Colomer; Christoph Hübner; Knut Brockmann; Lionel Van Maldergem; Manuel Schiff; Andreas Holzinger; Peter Barth; William Reardon; Michael Yourshaw; Stanley F Nelson; Thomas Eggermann; Klaus Zerres
Journal:  Neurology       Date:  2013-01-02       Impact factor: 9.910

Review 5.  Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia.

Authors:  Yasmin Namavar; Peter G Barth; Bwee Tien Poll-The; Frank Baas
Journal:  Orphanet J Rare Dis       Date:  2011-07-12       Impact factor: 4.123

6.  Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration.

Authors:  Jijun Wan; Michael Yourshaw; Hafsa Mamsa; Sabine Rudnik-Schöneborn; Manoj P Menezes; Ji Eun Hong; Derek W Leong; Jan Senderek; Michael S Salman; David Chitayat; Pavel Seeman; Arpad von Moers; Luitgard Graul-Neumann; Andrew J Kornberg; Manuel Castro-Gago; María-Jesús Sobrido; Masafumi Sanefuji; Perry B Shieh; Noriko Salamon; Ronald C Kim; Harry V Vinters; Zugen Chen; Klaus Zerres; Monique M Ryan; Stanley F Nelson; Joanna C Jen
Journal:  Nat Genet       Date:  2012-04-29       Impact factor: 38.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.